ARCHIVES

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Pinkel Corrects Report On ALL – Two Drugs Are Better Than One

April 21, 1978

CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell

November 12, 1976

Top 42 CCOPs (According To Priority Scores) Identified; Present Budget Would Draw Payline At 230

April 3, 1987

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Young Investigator Grants Available

July 8, 1977